Login or Register
Biomedical Learning Institute Taught by the Experts
Thought Leaders
Biomedical Learning Institute
Please Note: The Oncology Learning Center has changed its name to Biomedical Learning Institute
Co-Chairs
David R. Gandara, MD
Professor of Medicine
Division of Hematology/Oncology
Associate Director for Clinical Research
Director, Thoracic Oncology Program
UC Davis Cancer Center
Sacramento, CA


  Rafael Rosell, MD, PhD
Chief, Medical Oncology Service
Scientific Director of Oncology Research
Catalan Institute of Oncology
Hospital Germans Trias I Pujol
Barcelona, Spain
Other Expert Faculty
Daniel F. Hayes, MD
Professor, Department of Internal Medicine
Co-Director, Breast Care Center
Clinical Director, Breast Oncology Program
University of Michigan
Comprehensive Cancer Center
Ann Arbor, MI


  Soonmyung Paik, MD
Director, Division of Pathology
National Surgical Adjuvant Breast
and Bowel Project (NSABP)
Pittsburgh, PA
Edith A. Perez, MD
Serene M. and Frances C. Durling Professor of Medicine
Division of Hematology/Oncology
Director, Clinical Investigations
Director, Breast Cancer Program
Chair, Breast Committee for the North Central Cancer Treatment Group (NCCTG)
Mayo Clinic
Jacksonville, FL
  Lajos Pusztai, MD, DPhil, FACP
Associate Professor of Medicine
Department of Breast Medical Oncology
The University of Texas
M. D. Anderson Cancer Center
Houston, TX
   
Educational Statement of Need
Executive Summary
Learning Objectives
Disclosure
Target Audience
CME Credit Information
Agenda
Location and Travel Information
Registration
   

Agenda Back to Top
May 30, 2008 - Friday
6:00PM – 6:30PM Registration and dinner Sheraton Ballroom 1-3
6:30PM – 6:35PM Welcome and introductions David R. Gandara, MD and
Rafael Rosell, MD, PhD
6:35PM – 6:50PM Moving towards personalized cancer therapy David R. Gandara, MD
6:50PM – 7:05PM Molecular biomarkers of taxane sensitivity and resistance Rafael Rosell, MD, PhD
7:05PM – 7:20PM The role of SPARC in enhanced uptake of chemotherapy in tumors Edith A. Perez, MD
7:20PM – 7:30PM Questions and answers Faculty and audience
7:30PM – 7:45PM Genetic signatures as prognostic indicators for breast cancer Soonmyung Paik, MD
7:45PM – 8:00PM Gene expression profiling-based prediction of complete pathologic response to neoadjuvant taxane/FAC chemotherapy in breast cancer Lajos Pusztai, MD, DPhil, FACP
8:00PM – 8:15PM The relationship between HER2 expression and response to taxanes Daniel F. Hayes, MD
8:15PM – 8:30PM Questions and answers and concluding remarks Faculty and audience
Educational Grants

Sincere appreciation is extended to the following companies for their generous support of this educational meeting: Abraxis BioScience, AstraZeneca, Genomic Health

© 2012 Biomedical Learning Institute
1415 Legacy Drive, Suite 250 • Frisco, TX 75034 • Registration Phone: 214.269.2014 • Fax: 214.866.0311
Contact Us
Disclaimer: The material published on the Biomedical Learning Institute(BLI) Web site reflects the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the BLI, the CME provider, or the commercial supporters providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified physician should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any BLI materials. Click here for our Privacy Policy.